FR2046920B1
(en)
|
1969-06-19 |
1974-05-03 |
Citizen Watch Co Ltd |
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DE3422247A1
(en)
|
1984-06-15 |
1985-12-19 |
Pfeifer & Langen, 5000 Köln |
GLUCO-OLIGOSACCHARIDE MIXTURE AND METHOD FOR THE PRODUCTION THEREOF
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
WO1989004838A1
(en)
|
1987-11-25 |
1989-06-01 |
Immunex Corporation |
Interleukin-1 receptors
|
US5359037A
(en)
|
1988-09-12 |
1994-10-25 |
Yeda Research And Development Co. Ltd. |
Antibodies to TNF binding protein I
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
US4847745A
(en)
|
1988-11-16 |
1989-07-11 |
Sundstrand Corp. |
Three phase inverter power supply with balancing transformer
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5011778A
(en)
|
1989-05-23 |
1991-04-30 |
Otsuka Pharmaceutical Co., Ltd. |
Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
DE3920358A1
(en)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
|
AU639754B2
(en)
|
1989-12-20 |
1993-08-05 |
Schering Corporation |
Antibody antagonists of human interleukin-4
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
DK0506574T3
(en)
|
1991-03-29 |
1996-04-09 |
Sanofi Sa |
Protein with cytokine-type activity, recombinant DNA encoding this protein, cells and transformed microorganisms
|
MX9204374A
(en)
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
RECOMBINANT ANTIBODY AND METHOD FOR ITS PRODUCTION.
|
US5994514A
(en)
|
1991-08-14 |
1999-11-30 |
Genentech, Inc. |
Immunoglobulin variants
|
US6329509B1
(en)
|
1991-08-14 |
2001-12-11 |
Genentech, Inc. |
Anti-IgE antibodies
|
US5965709A
(en)
|
1991-08-14 |
1999-10-12 |
Genentech, Inc. |
IgE antagonists
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
ATE297465T1
(en)
|
1991-11-25 |
2005-06-15 |
Enzon Inc |
METHOD FOR PRODUCING MULTIVALENT ANTIGEN-BINDING PROTEINS
|
DE69334255D1
(en)
|
1992-02-06 |
2009-02-12 |
Novartis Vaccines & Diagnostic |
Marker for cancer and biosynthetic binding protein for it
|
AU3658093A
(en)
|
1992-02-10 |
1993-09-03 |
Seragen, Inc. |
Desensitization to specific allergens
|
WO1993016177A1
(en)
|
1992-02-11 |
1993-08-19 |
Cell Genesys, Inc. |
Homogenotization of gene-targeting events
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5550045A
(en)
|
1992-05-15 |
1996-08-27 |
Unilever Patent Holdings, B.V. |
Cloning and expression of DNA encoding a ripening form of a polypeptide having rhamnogalcturonase activity
|
US5397703A
(en)
|
1992-07-09 |
1995-03-14 |
Cetus Oncology Corporation |
Method for generation of antibodies to cell surface molecules
|
US5596072A
(en)
|
1992-08-21 |
1997-01-21 |
Schering Corporation |
Method of refolding human IL-13
|
AU5010793A
(en)
|
1992-08-21 |
1994-03-15 |
Schering Corporation |
Human interleukin-13
|
EP0752248B1
(en)
|
1992-11-13 |
2000-09-27 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
EP0866130B1
(en)
|
1993-05-17 |
2010-07-21 |
Genentech, Inc. |
CHO cell sialidase by recombinant DNA technology
|
WO1995006481A1
(en)
|
1993-09-02 |
1995-03-09 |
Trustees Of Dartmouth College |
Methods for inducing antigen-specific t cell tolerance
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
GB9415379D0
(en)
|
1994-07-29 |
1994-09-21 |
Smithkline Beecham Plc |
Novel compounds
|
US5705154A
(en)
|
1995-03-08 |
1998-01-06 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
US6518061B1
(en)
|
1995-03-15 |
2003-02-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
US6037453A
(en)
|
1995-03-15 |
2000-03-14 |
Genentech, Inc. |
Immunoglobulin variants
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
ES2334408T3
(en)
|
1995-10-23 |
2010-03-09 |
Zenyth Operations Pty Ltd |
HEMATOPOYETINE RECEIVER AND GENETIC SEQUENCES THAT CODE IT.
|
US6911530B1
(en)
|
1995-10-23 |
2005-06-28 |
Amrad Operations, Pty., Ltd. |
Haemopoietin receptor and genetic sequences encoding same
|
FR2742156A1
(en)
|
1995-12-06 |
1997-06-13 |
Sanofi Sa |
IL-13 RECEPTOR POLYPEPTIDE
|
SI9720020B
(en)
|
1996-02-09 |
2001-12-31 |
Basf Ag |
Human antibodies that bind human TNF alpha
|
US7078494B1
(en)
|
1996-03-01 |
2006-07-18 |
Genetics Institute, Llc |
Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
|
US6664227B1
(en)
|
1996-03-01 |
2003-12-16 |
Genetics Institute, Llc |
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
|
US5710023A
(en)
|
1996-03-01 |
1998-01-20 |
Genetics Institute, Inc. |
IL-13 cytokine receptor chain
|
WO1997047742A1
(en)
|
1996-06-12 |
1997-12-18 |
Smithkline Beecham Corporation |
Hr-1 receptor
|
WO1998010638A1
(en)
|
1996-09-10 |
1998-03-19 |
Amrad Operations Pty. Ltd. |
Therapeutic molecules
|
DK1864999T3
(en)
|
1996-11-27 |
2009-06-29 |
Genentech Inc |
Affinity purification of polypeptide on protein A matrix
|
GB9625899D0
(en)
|
1996-12-13 |
1997-01-29 |
Glaxo Group Ltd |
Substances and their uses
|
US6743604B1
(en)
|
1996-12-13 |
2004-06-01 |
Smithkline Beecham Corporation |
Substances and their uses
|
JP2001508441A
(en)
|
1997-01-10 |
2001-06-26 |
バイオジェン インコーポレイテッド |
Treatment of lupus nephritis with anti-CD40L compounds
|
ATE244579T1
(en)
|
1997-01-22 |
2003-07-15 |
Univ Texas |
TISSUE FACTOR METHODS AND COMPOSITIONS FOR COAGULATION AND TREATMENT OF TUMORS
|
US6576232B1
(en)
|
1998-04-03 |
2003-06-10 |
The Penn State Research Foundation |
IL13 mutants
|
US6482403B1
(en)
|
1998-05-29 |
2002-11-19 |
Heska Corporation |
Caniney IL-13 immunoregulatory proteins and uses thereof
|
US6299875B1
(en)
|
1998-06-04 |
2001-10-09 |
Panacea Pharmaceuticals, Llc |
Methods to block IGE binding to cell surface receptors of mast cells
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
US7083950B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
DE19848026A1
(en)
|
1998-10-17 |
2000-04-20 |
Bayer Ag |
Production of bis(4-hydroxyaryl)alkane, useful in production of polymer, e.g. polycarbonate or epoxide, involves using circulating inert gas for stripping aromatic hydroxyl compound from adduct
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US7553487B2
(en)
|
1998-12-14 |
2009-06-30 |
Genetics Institute, Llc |
Method and compositions for treating asthma
|
AU780031B2
(en)
|
1998-12-14 |
2005-02-24 |
Genetics Institute, Llc |
Cytokine receptor chain
|
WO2000044407A2
(en)
|
1999-02-01 |
2000-08-03 |
Amgen Canada |
Materials and methods to inhibit hodgkin and reed sternberg cell growth
|
CA2404763A1
(en)
|
1999-11-11 |
2001-05-17 |
Raj K. Puri |
Mutated il-13 molecules and their uses
|
US20100041039A1
(en)
|
2000-01-15 |
2010-02-18 |
Synageva Biopharma Corp. |
Analysis of nucleic acid obtained from nucleated red blood cells
|
CN101670105B
(en)
|
2000-02-24 |
2014-08-06 |
华盛顿大学 |
Humanized antibodies chelated with amylord beta peptide
|
PT1270595E
(en)
|
2000-03-03 |
2008-09-16 |
Kyowa Hakko Kogyo Kk |
Anti ccr4 antibody and its fragment
|
CN1323812A
(en)
|
2000-05-16 |
2001-11-28 |
上海博德基因开发有限公司 |
New polypeptide-human interleukin-13 (IL-13) receptor 11 and polynucleotides for coding same
|
WO2002055100A2
(en)
|
2000-10-20 |
2002-07-18 |
Genetics Institute, Llc |
Method and composition for inhibition of tumor growth and enhancing an immune response
|
EP1327681A4
(en)
|
2000-10-20 |
2004-09-01 |
Chugai Pharmaceutical Co Ltd |
Degraded agonist antibody
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
CA2447832C
(en)
|
2000-12-22 |
2012-09-25 |
Jamshid Tanha |
Phage display libraries of human vh fragments
|
JP2005518336A
(en)
|
2001-06-26 |
2005-06-23 |
イムクローン システムズ インコーポレイティド |
Bispecific antibody binding to VEGF receptor
|
US20030023555A1
(en)
|
2001-07-26 |
2003-01-30 |
Cashworks, Inc. |
Method and system for providing financial services
|
KR100959248B1
(en)
|
2001-08-31 |
2010-05-26 |
교와 핫꼬 기린 가부시키가이샤 |
Human CDR-grafted antibodies and antibody fragments thereof
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
JP2005289809A
(en)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
Mutant heavy-chain antibody
|
US20030235555A1
(en)
|
2002-04-05 |
2003-12-25 |
David Shealey |
Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
|
JP2005512522A
(en)
|
2001-10-26 |
2005-05-12 |
セントカー・インコーポレーテツド |
IL-13 mutein proteins, antibodies, compositions, methods and uses
|
BR0213950A
(en)
|
2001-11-07 |
2004-08-24 |
Cytos Biotechnology Ag |
Antigen Arrangements for the Treatment of Allergic Eosinofolic Diseases
|
ES2319636T3
(en)
|
2002-02-05 |
2009-05-11 |
Genentech, Inc. |
PURIFICATION OF PROTEINS.
|
US20040060102A1
(en)
|
2002-04-10 |
2004-04-01 |
Interspiro, Inc. |
Garments for biological, chemical and fire protection
|
US7323553B2
(en)
|
2002-04-26 |
2008-01-29 |
Genentech, Inc. |
Non-affinity purification of proteins
|
CA2489540A1
(en)
|
2002-06-14 |
2003-12-31 |
The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Office Of Technology Transfer |
Methods of treating and preventing colitis involving il-13 and nk-t cells
|
AU2003260748A1
(en)
|
2002-08-30 |
2004-03-19 |
Glaxo Group Limited |
Il-14 vaccine for the treatment of asthma and atopic disorders
|
JP2006503017A
(en)
|
2002-08-30 |
2006-01-26 |
グラクソ グループ リミテッド |
Immunogenic composition comprising IL-13 element and T cell epitope and therapeutic use thereof
|
DE10303664A1
(en)
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Detection molecules for the treatment and detection of tumors
|
WO2004071408A2
(en)
|
2003-02-10 |
2004-08-26 |
Applied Molecular Evolution, Inc. |
Aβ BINDING MOLECULES
|
US7157276B2
(en)
|
2003-06-20 |
2007-01-02 |
Biogen Idec Inc. |
Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
|
PL1639011T3
(en)
|
2003-06-30 |
2009-05-29 |
Domantis Ltd |
Pegylated single domain antibodies (dAb)
|
GB0407315D0
(en)
|
2003-07-15 |
2004-05-05 |
Cambridge Antibody Tech |
Human antibody molecules
|
SG10201900535UA
(en)
*
|
2003-12-23 |
2019-02-27 |
Genentech Inc |
Novel anti-il 13 antibodies and uses thereof
|
PT2311873T
(en)
|
2004-01-07 |
2018-11-20 |
Novartis Vaccines & Diagnostics Inc |
M-csf-specific monoclonal antibody and uses thereof
|
US20080261249A1
(en)
|
2004-01-13 |
2008-10-23 |
Genentech, Inc |
Detecting and Quantifying Host Cell Proteins in Recombinant Protein Products
|
JP2008507253A
(en)
|
2004-02-06 |
2008-03-13 |
ナイモックス コーポレーション |
Humanized antibody
|
PL1720909T3
(en)
|
2004-02-23 |
2012-04-30 |
Lilly Co Eli |
Anti-abeta antibody
|
US20070037966A1
(en)
*
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
ATE455861T1
(en)
|
2004-05-04 |
2010-02-15 |
Novo Nordisk Healthcare Ag |
O-LINKED GLYCOFORMS OF FACTOR VII AND METHOD FOR THE PRODUCTION THEREOF
|
US20070048785A1
(en)
|
2004-06-09 |
2007-03-01 |
Lin Laura L |
Anti-IL-13 antibodies and complexes
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
AR049390A1
(en)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
ANTIBODIES AGAINST HUMAN INTERLEUQUINE-13 AND USES OF THE SAME
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
JP5553963B2
(en)
|
2004-10-22 |
2014-07-23 |
アムジエン・インコーポレーテツド |
Methods for refolding recombinant antibodies
|
CN101102670B
(en)
|
2004-12-24 |
2011-10-26 |
联邦科学技术研究组织 |
Pesticide compositions and methods
|
PL1869065T3
(en)
|
2005-03-11 |
2020-09-21 |
Wyeth Llc |
A method of weak partitioning chromatography
|
US8129508B2
(en)
|
2005-04-11 |
2012-03-06 |
Medarex, Inc. |
Protein purification using HCIC and ion exchange chromatography
|
EP2388274A1
(en)
|
2005-06-17 |
2011-11-23 |
Janssen Alzheimer Immunotherapy |
Methods of purifying anti A Beta antibodies
|
JP3982545B2
(en)
|
2005-09-22 |
2007-09-26 |
ダイキン工業株式会社 |
Air conditioner
|
BRPI0616359B8
(en)
*
|
2005-09-30 |
2022-08-30 |
Medimmune Ltd |
PHARMACEUTICAL COMPOSITION, PROCESS FOR PURIFICATION OF AN IL-13 ANTIBODY AND USE OF A PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY
|
EP2532678A1
(en)
|
2005-10-21 |
2012-12-12 |
Novartis AG |
Human antibodies against il13 and therapeutic uses
|
CN101506236B
(en)
|
2005-11-30 |
2012-12-12 |
雅培制药有限公司 |
Monoclonal antibodies against amyloid beta protein and uses thereof
|
US7667557B2
(en)
|
2005-12-06 |
2010-02-23 |
Tdk Corporation |
Thin-film bandpass filter using inductor-capacitor resonators
|
RU2015111675A
(en)
|
2005-12-12 |
2015-08-10 |
Ац Иммуне Са |
SPECIFIC IN RESPECT TO AMYLOID BETA (A BETA) 1-42 MONOCLONAL ANTIBODIES WITH THERAPEUTIC PROPERTIES
|
PE20100684A1
(en)
|
2005-12-12 |
2010-10-04 |
Hoffmann La Roche |
ANTI B-4-AMYLOID ANTIBODY CONTAINING GLYCOSYLATED ASPARAGINE IN THE VARIABLE REGION OF VH
|
JP2009521909A
(en)
|
2005-12-30 |
2009-06-11 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Anti-IL-6 antibody that inhibits binding of IL-6 and IL-6Rα complex to gp130
|
US7563875B2
(en)
|
2006-03-20 |
2009-07-21 |
The United States of America as represented by the Sercretary of the Army |
Recombinant chimeric human anti-botulinum antibodies
|
SG170837A1
(en)
*
|
2006-04-05 |
2011-05-30 |
Abbott Biotech Ltd |
Antibody purification
|
US20070287160A1
(en)
|
2006-04-21 |
2007-12-13 |
Chou Judy H |
Methods for high throughput screening of cell lines
|
AR062065A1
(en)
|
2006-07-14 |
2008-10-15 |
Ac Immune Sa |
HUMANIZED ANTIBODY
|
CL2007002567A1
(en)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
ISOLATED PROTEINS FROM LINK TO ACTIVINE TO HUMAN.
|
WO2008036863A2
(en)
|
2006-09-21 |
2008-03-27 |
Verenium Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
KR20150002879A
(en)
|
2006-10-02 |
2015-01-07 |
에이씨 이뮨 에스.에이. |
Humanized antibody against amyloid beta
|
PL2457929T3
(en)
|
2006-10-04 |
2016-12-30 |
|
ELISA for VEGF
|
US8383350B1
(en)
|
2006-12-20 |
2013-02-26 |
Merck Sharp & Dohme Corp. |
Assay for detection of IL-10 antibodies
|
PE20081610A1
(en)
|
2007-01-09 |
2008-12-09 |
Wyeth Corp |
FORMULATIONS OF ANTI-IL-13 ANTIBODIES AND USES OF THEM
|
WO2008140455A1
(en)
|
2007-05-15 |
2008-11-20 |
Tanox, Inc. |
Treatment of radiation and chemo-therapy induced fibrosis using novel anti-il 13 monoclonal antibodies
|
KR20160017126A
(en)
|
2007-06-12 |
2016-02-15 |
에이씨 이뮨 에스.에이. |
Monoclonal anti beta amyloid antibody
|
MX2009013505A
(en)
|
2007-06-12 |
2010-01-27 |
Ac Immune Sa |
Humanized antibodies to amyloid beta.
|
US9433922B2
(en)
|
2007-08-14 |
2016-09-06 |
Emd Millipore Corporation |
Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
|
US20100297012A1
(en)
|
2007-10-05 |
2010-11-25 |
Andrea Pfeifer |
Humanized antibody
|
AU2008311365B2
(en)
|
2007-10-05 |
2015-03-12 |
Ac Immune S.A. |
Humanized antibody
|
CN101883790B
(en)
|
2007-10-05 |
2015-09-09 |
基因技术公司 |
The purposes of anti-amyloid beta antibody in illness in eye
|
WO2009058769A1
(en)
*
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
AU2009231733B2
(en)
|
2008-03-31 |
2015-12-24 |
Genentech, Inc. |
Compositions and methods for treating and diagnosing asthma
|
WO2009131643A1
(en)
|
2008-04-21 |
2009-10-29 |
Monabio, Inc. |
Immunoassay for specific determination of s-adenosymethionine and analogs thereof in biological samples
|
WO2009136286A2
(en)
|
2008-05-05 |
2009-11-12 |
Novimmune Sa |
Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
|
AU2009278386B2
(en)
|
2008-08-05 |
2015-05-21 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and prevention of cancers
|
US8790642B2
(en)
*
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
GB0818674D0
(en)
|
2008-10-10 |
2008-11-19 |
Univ Bath |
Materials and methods for resolving polyhydric species by electrophoresis
|
NZ592097A
(en)
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Viral inactivation during purification of il-12 and il-18 antibodies
|
CA2911256A1
(en)
|
2008-10-20 |
2010-12-09 |
Robert K. Hickman |
Isolation and purification of antibodies using protein a affinity chromatography
|
US20100111853A1
(en)
|
2008-10-20 |
2010-05-06 |
Abbott Laboratories, Inc. |
Antibodies that bind to il-12 and methods of purifying the same
|
TW201030016A
(en)
|
2008-10-20 |
2010-08-16 |
Abbott Lab |
Antibodies that bind to IL-18 and methods of purifying the same
|
CN101979404B
(en)
|
2008-12-09 |
2015-01-14 |
厦门大学 |
Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof
|
FR2944448B1
(en)
|
2008-12-23 |
2012-01-13 |
Adocia |
STABLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE MONODONAL ANTIBODY AND AT LEAST ONE AMPHIPHILIC POLYSACHARIDE COMPRISING SUBSTITUENTS DERIVED FROM HYDROFOB ALCOHOLS OR HYDROPHOBIC AMINES.
|
WO2011010940A1
(en)
|
2009-07-19 |
2011-01-27 |
Serguei Zavtrak |
Solar electric power generator
|
RU2573894C2
(en)
|
2009-08-06 |
2016-01-27 |
Дженентек, Инк. |
Method for improving process of elimination of viruses in protein purification
|
US8709424B2
(en)
|
2009-09-03 |
2014-04-29 |
Merck Sharp & Dohme Corp. |
Anti-GITR antibodies
|
UA109884C2
(en)
|
2009-10-16 |
2015-10-26 |
|
A POLYPEPTIDE THAT HAS THE ACTIVITY OF THE PHOSPHATIDYLINOSYTOL-SPECIFIC PHOSPHOLIPASE C, NUCLEIC ACID, AND METHOD OF METHOD
|
MX2012004711A
(en)
|
2009-10-20 |
2012-05-23 |
Abbott Lab |
Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography.
|
RS62387B1
(en)
|
2010-01-29 |
2021-10-29 |
Chugai Pharmaceutical Co Ltd |
Anti-dll3 antibody
|
CA2791658C
(en)
|
2010-03-04 |
2019-10-01 |
Macrogenics, Inc. |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
DK3789038T3
(en)
|
2010-05-14 |
2022-10-17 |
Univ Leland Stanford Junior |
HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES AGAINST CD47
|
SG185583A1
(en)
|
2010-05-17 |
2012-12-28 |
Livtech Inc |
Anti-human trop-2 antibody having antitumor activity in vivo
|
CA2799915C
(en)
|
2010-05-25 |
2023-09-26 |
Genentech, Inc. |
Methods of purifying polypeptides
|
US8603478B2
(en)
|
2010-07-06 |
2013-12-10 |
Aveo Pharmaceuticals, Inc. |
Anti-RON antibodies
|
RU2607368C2
(en)
|
2010-07-30 |
2017-01-10 |
Ац Иммуне С.А. |
Safe and functional humanized antibodies
|
WO2012047732A2
(en)
|
2010-09-29 |
2012-04-12 |
Genentech, Inc. |
Antibody compositions and methods of use
|
KR102099462B1
(en)
*
|
2010-11-30 |
2020-04-10 |
제넨테크, 인크. |
Low affinity blood brain barrier receptor antibodies and uses therefor
|
BR112013013460A8
(en)
|
2010-12-16 |
2019-02-12 |
Genentech Inc |
methods for identifying an asthma patient, method for monitoring an asthma patient, use of a total periostin detection kit, total periostin measurement kit, use of an anti-il-13 antibody, use of a therapeutically amount lebrikizumab therapy, use of a th2 pathway inhibitor, adverse event evaluation method, anti-periostin antibody, and total periostin test
|
CA2833636A1
(en)
|
2011-04-20 |
2012-10-26 |
Amplimmune, Inc. |
Antibodies and other molecules that bind b7-h1 and pd-1
|
EP2773439A4
(en)
*
|
2011-10-31 |
2015-07-01 |
Merck Sharp & Dohme |
Chromatography process for resolving heterogeneous antibody aggregates
|
CN108704132A
(en)
|
2011-10-31 |
2018-10-26 |
弗·哈夫曼-拉罗切有限公司 |
Antibody preparation
|
RU2014124842A
(en)
*
|
2011-11-21 |
2015-12-27 |
Дженентек, Инк. |
CLEANING ANTI-C-MET ANTIBODIES
|
BR112014011900A2
(en)
|
2011-12-15 |
2017-05-16 |
Hanwha Chemical Corp |
an antibody purification method
|
WO2013120497A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
SG10201610788VA
(en)
|
2012-02-29 |
2017-03-30 |
Gilead Biologics Inc |
Antibodies to matrix metalloproteinase 9
|
RU2016107435A
(en)
*
|
2013-09-13 |
2017-10-18 |
Дженентек, Инк. |
COMPOSITIONS AND METHODS FOR DETECTING AND QUANTITATIVE DETERMINATION OF THE PROTEIN OF CELLS-OWNERS IN CELL LINES AND RECOMBINANT POLYPEPTIDE PRODUCTS
|
WO2015038888A1
(en)
*
|
2013-09-13 |
2015-03-19 |
Genentech, Inc. |
Methods and compositions comprising purified recombinant polypeptides
|